Enhancing the QUAlity and Transparency Of health Research

Website translation help
Navigate this website
Home > Library > Reporting guideline > GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials

Search for reporting guidelines

Use your browser's Back button to return to your search results

GNOSIS : guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)		 Phase 1 and phase 2 clinical trials in neuro-oncology
Full bibliographic reference Chang SM, Reynolds SL, Butowski N, Lamborn KR, Buckner JC, Kaplan RS, Bigner DD. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol. 2005;7(4):425-434.
Language English
PubMed ID 16212807
Reporting guideline acronym GNOSIS
Study design Clinical trials, Experimental studies
Clinical area Neurology, Oncology
Applies to the whole report or to individual sections of the report? Whole report
Record last updated on October 24, 2013

Reporting guidelines for main study types

Translations

Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.

Library index